Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, reflecting a minor metadata update to the document version.
    Difference
    0.0%
    Check dated 2026-06-05T11:48:01.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.3 to v3.5.4, signaling a minor update to the site. This change does not appear to modify the study details or user-visible information.
    Difference
    0.0%
    Check dated 2026-05-15T05:46:55.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The page’s footer/version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-24T05:59:03.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:40:23.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added Cutaneous neuroendocrine carcinoma as a related MeSH term and added a Resources link to the Genetic and Rare Diseases Information Center.
    Difference
    0.1%
    Check dated 2026-04-02T15:37:41.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T05:59:31.000Z thumbnail image

Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.